PATENT CLAIM ANALYSIS

Application Number: 16020688
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "267000"]

Abstract:
The present invention provides, inter alia, compounds capable of inhibiting NF-κB. Pharmaceutical compositions containing and methods of using the compounds are also provided herein. Also provided are methods and kits for treating cancer and solid tumors in a subject, as well as methods and kits for inducing cancer cell death and apoptosis of a cancer cell, all utilizing the NF-κB inhibitors described herein.

Claim (Index 40):
The method according to  claim 39 , wherein the cancer cell is selected from the group consisting of lung cancer cell, pancreatic cancer cell, liver cancer cell, colorectal cancer cell, gastric cancer cell, and breast cancer cell.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 94.0
- Lexical Diversity: 1.59091
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15393507', '12604970', '14032739', '13035640', '14088804']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8152632503631568
- 35 USC 102 Novelty (BERT): 0.5560068743778264
- Combined Prediction Score: 0.7893376127646239
- Mean Citation Score: 335.78576400000014
- Max Citation Score: 451.7303
- Similarity Product: 324.1126539440752

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test